Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Change in Directorate
Re-appointment of Sujana Shah (DIN: 08100410) as an Independent Director of the Company for second term of 5 years w.e.f. May 7, 2023.19-10-2022
19-10-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Vijay Kedia (DIN: 00230480) as an Additional Director (Non Executive - Non Independent) Director of the Company w.e.f. 18-Oct-202219-10-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation of Grant of Options under Shalby Limited Employees Stock Options Scheme - 202118-10-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for Quarter ended September 30, 2022.18-10-2022
Q2FY23 Quarterly Result Announced for Shalby Ltd.
Healthcare facilities company Shalby announced Q2FY23 results: Total Revenues of Rs. 1,830 million, growth of 13.5% YoY (excluding vaccination and covid revenue) EBITDA of Rs. 437 million with EBITDA margins of 24% Profit After Tax was Rs. 218 million, growth of 31% YoY Basic EPS of Rs. 2.03, growth of 32% YoY Bed occupied during the quarter were 600, with occupancy rate of 16% In patients count of 12,606, growth of 19% YoY Total Surgery count of 6.806, growth of 10% YoY Result PDF18-10-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release dated 18-Oct-2022 titled Stellar Q2 FY23 performance by Shalby hospital with PAT up by 31% YoY of Rs 218 million18-10-2022
Shalby Ltd - 540797 - Outcome Of Board Meeting Held On 18-Oct-2022 For Approval Of Standalone And Consolidated Financial Statements For The Quarter And Half Year Ended September 30, 2022
Outcome of Board Meeting held on 18-Oct-2022 for approval of standalone and consolidated financial statements for the quarter and half year ended September 30, 202218-10-2022
Shalby Ltd - 540797 - Board Meeting Outcome for Outcome Of Board Meeting Held On 18-Oct-2022 For Approval Of Standalone And Consolidated Financial Statements For The Quarter And Half Year Ended September 30, 2022
Outcome of Board Meeting held on 18-Oct-2022 for approval of standalone and consolidated financial statements for the quarter and half year ended September 30, 202218-10-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analysts/Institutional Investor Meet/Con. Call to be held on October 20, 2022 to discuss Unaudited Financial Results for quarter and half year ended September 30, 2022.15-10-2022